Breast Cancer Therapy Market is Estimated to be USD 63.13 Billion by 2032 with a CAGR of 8.5% | Polaris Market Research
13 sept. 2024 08h00 HE
|
Polaris Market Research & Consulting LLP
New York, USA, Sept. 13, 2024 (GLOBE NEWSWIRE) -- Market Overview: The global breast cancer therapy market size is predicted to grow from USD 30.90 billion in 2023 to USD 63.13 billion by 2032....
Atossa Therapeutics Announces Support of Final Rule from FDA Requiring Patient Notification of Breast Density, a Critical Step in Addressing a Known Risk Factor for Breast Cancer
10 sept. 2024 08h30 HE
|
Atossa Therapeutics, Inc.
SEATTLE, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), today announced its support of the U.S. Food and Drug Administration (FDA) for...
Europe Breast Cancer Screening Market Forecast Report and Company Analysis 2024-2032 Featuring AstraZeneca, Novartis, Sanofi, Pfizer, Bayer, and GlaxoSmithKline
04 sept. 2024 10h39 HE
|
Research and Markets
Dublin, Sept. 04, 2024 (GLOBE NEWSWIRE) -- The "Europe Breast Cancer Screening Market Forecast Report by Europe Breast Cancer Screening Market, Countries, and Company Analysis, 2024-2032" report has...
Arvinas to Participate in Upcoming Investor Conferences
29 août 2024 07h00 HE
|
Arvinas Inc.
NEW HAVEN, Conn., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today...
Sermonix Pharmaceuticals Completes Enrollment of Phase 2 I-SPY 2 Arm Evaluating Lasofoxifene in Neoadjuvant Breast Cancer Setting
27 août 2024 09h00 HE
|
Sermonix Pharmaceuticals Inc.
COLUMBUS, Ohio and SAN FRANCISCO, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative therapeutics to specifically treat...
Companion Diagnostics Market Size to Hit USD 9.3 Billion Revenue by 2028 with 9% CAGR: Report by Transparency Market Research
20 août 2024 10h38 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Transparency Market Research Inc., Aug. 20, 2024 (GLOBE NEWSWIRE) -- The global companion diagnostics market (동반진단 시장) was worth US$ 5.2 Bn in 2020 and is...
Atossa Therapeutics Announces Second Quarter 2024 Financial Results and Provides Corporate Update
12 août 2024 08h30 HE
|
Atossa Therapeutics, Inc.
Presented data showing 100% disease control rate after 24-week treatment with (Z)-Endoxifen in 40mg cohort of Phase 2 EVANGELINE study at the American Association for Cancer Research (AACR) Annual...
Elucent Medical Announces Froedtert & the Medical College of Wisconsin Health Network to Provide New Breast Cancer Surgical Technology
09 août 2024 08h00 HE
|
Elucent
EDEN PRAIRIE, Minn., Aug. 09, 2024 (GLOBE NEWSWIRE) -- Elucent Medical, a pioneering medical technology company transforming the field of guided surgical technology, is thrilled to announce...
Olema Oncology Reports Second Quarter 2024 Financial Results and Provides Corporate Update
06 août 2024 16h02 HE
|
Olema Oncology
Presented promising interim clinical results from the ongoing study of palazestrant in combination with ribociclib at the 2024 ESMO Breast Cancer Congress. Updated results expected to be presented at...
Processa Pharmaceuticals Announces FDA Clearance of IND Application for a Phase 2 Clinical Trial of NGC-Cap in Breast Cancer
30 juil. 2024 08h00 HE
|
Processa Pharmaceuticals, Inc.
Open-label Phase 2 trial in breast cancer to begin this quarter Initial data expected mid-2025 HANOVER, Md., July 30, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA)...